The impact of cancer expectations on psychological responses following a cancer signal detected result in asymptomatic multi-cancer detection (MCED) testing
- PMID: 40926064
- PMCID: PMC12603331
- DOI: 10.1038/s41416-025-03180-5
The impact of cancer expectations on psychological responses following a cancer signal detected result in asymptomatic multi-cancer detection (MCED) testing
Abstract
Background: Multi-cancer detection (MCED) blood tests have the potential to screen for early-stage cancers. Understanding how people experience an MCED cancer signal result is vital prior to any future implementation. We explored experiences in a trial context.
Methods: A subset of 41 participants in the NHS-Galleri trial (NCT05611632), with a cancer signal detected result, were interviewed. We selected: 20 participants with cancer found (self-reported) and 21 without cancer (following tests). Transcripts were analysed thematically.
Results: Expectations of cancer played a pivotal role in emotional, cognitive and social responses, and were influenced by participants' experiences of health and symptoms. While the cancer signal was often unexpected, the predicted cancer signal origin made sense when consistent with family history or health issues. During the period of diagnostic uncertainty, views of healthiness or lack of family history were sometimes used to self-reassure. For some, a cancer diagnosis was unexpected; for others, expectations of cancer had gradually increased. For those without cancer, believing that it could be present affected their sense of reassurance.
Discussion: Information about the meaning of a cancer signal will be needed if MCED screening is implemented. Patient support could be designed around their expectations of cancer at each stage.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: JW reports research income from GRAIL Bio UK, Ltd., which funded 20% of her salary (2021–2024) and the full salaries of LAVM (2021–2025) and NSB (2021–2023) through a contract with King’s College London/Queen Mary University of London. Ethics approval and consent to participate: Ethics approval was granted by the Wales Research Ethics Committee as part of the NHS-Galleri trial (Ref 21/WA/0141). Full consent for the interview was collected prior to participation. This study was performed in accordance with the Declaration of Helsinki.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
